News and Trends 23 May 2023
HuidaGene Therapeutics creates world’s first ‘G to Y’ DNA base-editor
HuidaGene Therapeutics, a clinical-stage genome-editing company, says the National Science Review has published data from its study of the world's first DNA base editor converting guanine to cytosine/thymine (pyrimidine), or…